Senotherapeutics Biomarker Consortium: Inaugural Summit

The Senotherapeutics Biomarker Consortium (SBC) Inaugural Summit is a landmark scientific gathering convened by the Phaedon Institute — a nonprofit organization dedicated to advancing the science of longevity and cellular senescence through research, education, and cross-sector collaboration. This inaugural summit unites leading academics, clinicians, biotechnology executives, and regulatory experts to address one of the most critical challenges in aging biology: the development, standardization, and clinical translation of senescence biomarkers. By bringing together diverse stakeholders across the full translational spectrum, the SBC aims to accelerate the path from mechanistic discovery to actionable clinical tools. Program Sessions: Session 1 — Basic Science & Biomarker Discovery Session 2 — Clinical Biomarkers & Trials Session 3 — Therapeutics & Biomarker Integration Industry Spotlight — Perspectives from Industry Partners Working Groups — Parallel Breakout Sessions Perspectives — Regulation & Funding Landscape Round Table — Where Does the Field Go From Here? Focused Networking Event Hosts & Organizers: Marco Demaria — ERIBA, University of Groningen Vidyani Suryadevara — Stanford University Nicola Neretti — Brown University Heinrich Jasper — Genentech, Inc. Marco Quarta — Rubedo Life Sciences, Inc. For full program details, visit phaedon.institute/sbc/ or phaedon.institute/summit/sbc-2026/ or contact [email protected] Please note that no food or drinks are permitted inside the Clark Center Auditorium at any time. Registration note: To maintain the quality of dialogue and ensure a peer-level audience, the hosts will conduct a light screening of registrations following submission.